Recalling firm
Contract Pharmaceuticals Limited Canada
Product type
Drug
Status
Terminated
Report date
2023-09-06
Distribution
Nationwide in the USA.
Firm state
N/A
Product quantity
11,350 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall
Defective Container: slow leakage under the cap
Product description
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
Code / lot info
Lot # 118920, exp. January 2024.
Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.